MOSFET detectors in quality assurance of tomotherapy treatments

被引:20
作者
Cherpak, Amanda [1 ]
Studinski, Ryan C. N. [1 ]
Cygler, Joanna E. [1 ]
机构
[1] Ottawa Hosp Reg Canc Ctr, Dept Med Phys, Ottawa, ON, Canada
关键词
MOSFET detectors; in vivo dosimetry; tomotherapy;
D O I
10.1016/j.radonc.2007.10.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The purpose of this work was to characterize metal oxide semiconductor field-effect transistors (MOSFETs) in a 6MV conventional linac and investigate their use for quality assurance of radiotherapy treatments with a tomotherapy Hi-Art unit. Materials and methods: High sensitivity and standard sensitivity MOSFETs were first calibrated and then tested for reproducibility, field size dependence, and accuracy of measuring surface dose in a 6 MV beam as well as in a tomotherapy Hi-Art unit. In vivo measurements were performed on both a RANDO phantom and several head and neck cancer patients treated with tomotherapy and compared to TLD measurements and treatment plan doses to evaluate the performance of MOSFETs in a high gradient radiation field. Results: The average calibration factor found was 0.345 +/- 2.5% cGy/mV for the high sensitivity MOSFETs tested and 0.901 +/- 2.4% cGy/mV for the standard sensitivity MOSFETs. MOSFET measured surface doses had an average agreement with ion chamber measurements of 1.55% for the high sensitivity MOSFET and 5.23% for the standard sensitivity MOSFET when averaged over all trials and field sizes tested. No significant dependence on field size was found for the standard sensitivity MOSFETs, however a maximum difference of 5.34% was found for the high sensitivity MOSFET calibration factors in the field sizes tested. Measurements made with MOSFETS on head and neck patients treated on a tomotherapy Hi-Art unit had an average agreement of (3.26 +/- 0.03)% with TLD measurements, however the average of the absolute difference between the MOSFET measurements and the treatment plan skin doses was (12.2 +/- 7.5)%. The MOSFET measured patient skin doses also had good reproducibility, with inter-fraction deviations ranging from 1.4% to 6.6%. Similar results were found from trials using a RANDO phantom. Conclusions: The MOSFETs performed well when used in the tomotherapy Hi-Art unit and did not increase the overall treatment set-up time when used for patient measurements. It was found that MOSFETs are suitable detectors for surface dose measurements in both conventional beam and tomotherapy treatments and they can provide valuable skin dose information in areas where the treatment planning system may not be accurate. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:242 / 250
页数:9
相关论文
共 50 条
  • [21] AAPM Task Group Report 306: Quality control and assurance for tomotherapy: An update to Task Group Report 148
    Chen, Quan
    Rong, Yi
    Burmeister, Jay W. W.
    Chao, Edward H. H.
    Corradini, Nathan A. A.
    Followill, David S. S.
    Li, X. Allen
    Liu, An
    Qi, X. Sharon
    Shi, Hairong
    Smilowitz, Jennifer B. B.
    [J]. MEDICAL PHYSICS, 2023, 50 (03) : E25 - E52
  • [22] IMPORTANCE OF IN-VIVO DOSIMETRY AS PART OF A QUALITY ASSURANCE PROGRAM IN TANGENTIAL BREAST TREATMENTS
    LEUNENS, G
    VANDAM, J
    DUTREIX, A
    VANDERSCHUEREN, E
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (01): : 285 - 296
  • [23] Evaluation of PTW Seven29 for tomotherapy patient-specific quality assurance and comparison with ScandiDos Delta(4)
    Myers, Pamela
    Stathakis, Sotirios
    Gutierrez, Alonso N.
    Esquivel, Carlos
    Mavroidis, Panayiotis
    Papanikolaou, Niko
    [J]. JOURNAL OF MEDICAL PHYSICS, 2012, 37 (02) : 72 - 80
  • [24] Implantable MOSFET detectors: Evaluation of a new design
    Briere, Tina Marie
    Gillin, Michael T.
    Beddar, A. Sam
    [J]. MEDICAL PHYSICS, 2007, 34 (12) : 4585 - 4590
  • [25] A correlation study between clinical dose distribution and gamma passing rates in pre-treatment Tomotherapy quality assurance
    Biondi, M.
    Vanzi, E.
    De Otto, G.
    Belmonte, G.
    Buonamici, F. Banci
    [J]. BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2019, 5 (04):
  • [26] Commissioning of an Adaptive Radiation Therapy module for Tomotherapy treatments
    Mateus, Josefina
    Girao, Mariana
    Capela, Miguel
    Santos, Tania
    Ventura, Tiago
    Lopes, Maria do Carmo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S4086 - S4088
  • [27] Performance evaluation of the RITG148+ set of TomoTherapy quality assurance tools using RTQA2 radiochromic film
    Lobb, Eric C.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (04): : 254 - 267
  • [28] Clinical implementation of MOSFET detectors for dosimetry in electron beams
    Bloemen-van Gurp, Esther J.
    Minken, Andre W. H.
    Mijnheer, Ben J.
    Dehing-Oberye, Cary J. G.
    Lambin, Philippe
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 (03) : 288 - 295
  • [29] Characterization of responses and comparison of calibration factor for commercial MOSFET detectors
    Bharanidharan, G
    Manigandan, D
    Devan, K
    Subramani, V
    Gopishankar, N
    Ganesh, T
    Joshi, R
    Rath, G
    Velmurugan, J
    Aruna, P
    Ganesan, S
    [J]. MEDICAL DOSIMETRY, 2005, 30 (04) : 213 - 218
  • [30] TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation
    Zani, M.
    Marrazzo, L.
    Calusi, S.
    Talamonti, C.
    Scoccianti, S.
    Greto, D.
    Desideri, I
    Fusi, F.
    Pallotta, S.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (02)